Technology: Biotechnology, Health Care, Therapeutics, Tumor-Specific Antigens
Industry: Clinical Development, Preclinical Development, Tumor-Specific Antigens
Headquarters: Emeryville, California, United States
Founded Date: 2015-08-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 16
Total Funding: 476000000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-09-16
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership